6.25 0.18(2.97%) Dec 6, 3:42PM EST
887 Great Northern Way
Vancouver, BC V5T 4T5
Canada - Map
QLT Inc., a biotechnology company, engages in the development and commercialization of ocular products that address the unmet medical needs of patients and clinicians worldwide. It focuses on the development of QLT091001, a synthetic retinoid compound, which is in Phase Ib retreatment clinical trials for the treatment of Leber Congenital Amaurosis and Retinitis Pigmentosa; and Phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65. The company was founded in 1981 and is headquartered in Vancouver, Canada.